Sen Baishali 4

4 · theMaven, Inc. · Filed Feb 2, 2021

Form 4

Period: 2017-11-17

Director

Transactions

Award
Options to purchase
2019-04-10+241,820→ 241,820 total
Exercise: $0.46Exp: 2029-04-10→ Common Stock (241,820 underlying)
Award
Common Stock
2019-01-01+104,167→ 123,398 total
Award
Options to purchase
2018-01-01+45,000→ 45,000 total
Exercise: $0.48From: 2019-01-31Exp: 2028-01-01→ Common Stock (45,000 underlying)
Award
Options to purchase
2017-11-17+7,500→ 7,500 total
Exercise: $1.20From: 2017-12-31Exp: 2027-11-17→ Common Stock (7,500 underlying)
Award
Common Stock
2020-02-06+62,500→ 185,898 total
Award
Common Stock
2021-01-01+83,333→ 269,231 total
Award
Common Stock
2018-10-01+19,231→ 19,231 total

Footnotes (3)

[F1]Vests in equal monthly installments commencing on the last day of the calendar month in which the Grant was made and ending on the December 31 of such year.
[F2]Vesting is a combined overlay of Time-based, Stock-Price-based, and Stock-Listing-based conditions. Time-based vesting is 1/3 vest after 1 year, with the balance monthly over next 2 years. Stock-Price vesting is a potential downward adjustment to the otherwise Time-based vested shares, where such adjustment is based on the rolling 45-day Volume Weighted Average Price set against specific price targets. Stock Listing vesting means that no otherwise Time-based and Stock Price-based vested shares are actually deemed as vested unless the Issuer's common stock is listed on a national securities exchange registered with the Securities and Exchange Commission under Section 6 of the Securities Exchange Act of 1934.
[F3]The ability to exercise is subject to both: i) vesting conditions (2) and ii) the Issuer's shareholders approving a requisite increase in authorized shares of common stock, after the date the grant was issued, that would apply to this grant.

Documents

1 file